Profile
Ola Melin is currently the Chief Operating Officer at Circio Holding ASA. Prior to this role, she worked as the Director of Technical Operations at OxThera AB and as the Director of Extended Manufacturing at Swedish Orphan Biovitrum AB. Ms. Melin completed her undergraduate degree at Mälardalen University.
Ola Melin active positions
| Companies | Position | Start |
|---|---|---|
| CIRCIO HOLDING ASA | Chief Operating Officer | - |
Former positions of Ola Melin
| Companies | Position | End |
|---|---|---|
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Chief Tech/Sci/R&D Officer | - |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - |
Training of Ola Melin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
Mälardalen University
Mälardalen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Circio Holding ASA
Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
- Stock Market
- Insiders
- Ola Melin
















